Randomized trial of albinterferon alfa-2b every 4 weeks for chronic hepatitis C virus genotype 2/3.

S Pianko, S Zeuzem, WL Chuang, GR Foster, SK Sarin, R Flisiak, Chuan-mo Lee, P Andreone, T Piratvisuth, S Shah, A. Sood, J George, M Gould, P Komolmit, S Thongsawat, T Tanwandee, J Rasenack, Y Li, M Pang, Y YinG Feutren, IM Jacobson

Research output: Contribution to journalJournal Article peer-review

10 Scopus citations

Fingerprint

Dive into the research topics of 'Randomized trial of albinterferon alfa-2b every 4 weeks for chronic hepatitis C virus genotype 2/3.'. Together they form a unique fingerprint.

Nursing and Health Professions

Biochemistry, Genetics and Molecular Biology

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science